COSMOPHOS-NANO

Novel nanotechnology-enabled system for endovascular in vivo near-infrared fluorescence molecular imaging and endovascular near-infrared targeted photodynamic therapy of atherosclerotic heart disease

 Coordinatore Itä-Suomen yliopisto 

 Organization address address: YLIOPISTONRANTA 1 E
city: Kuopio
postcode: 70211

contact info
Titolo: Ms.
Nome: Jaana
Cognome: Backman
Email: send email
Telefono: +35 8505554446

 Nazionalità Coordinatore Finland [FI]
 Sito del progetto http://www.cosmophos-nano.eu/
 Totale costo 12˙899˙591 €
 EC contributo 8˙503˙352 €
 Programma FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies
 Code Call FP7-NMP-2012-LARGE-6
 Funding Scheme CP-IP
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-03-01   -   2018-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    Nome Ente NON disponibile

 Organization address address: YLIOPISTONRANTA 1 E
city: Kuopio
postcode: 70211

contact info
Titolo: Ms.
Nome: Jaana
Cognome: Backman
Email: send email
Telefono: +35 8505554446

FI (Kuopio) coordinator 2˙029˙689.60
2 KOBENHAVNS UNIVERSITET DK participant 844˙768.00
3    UNIVERSIDAD AUTONOMA DE MADRID

 Organization address address: CALLE EINSTEIN, CIUDAD UNIV CANTOBLANCO RECTORADO 3
city: MADRID
postcode: 28049

contact info
Titolo: Prof.
Nome: Tomas
Cognome: Torres
Email: send email
Telefono: +34 914975151
Fax: +34 914973966

ES (MADRID) participant 679˙426.00
4    TECHNISCHE UNIVERSITAET MUENCHEN

 Organization address address: Arcisstrasse 21
city: MUENCHEN
postcode: 80333

contact info
Titolo: Ms.
Nome: Katrin
Cognome: Hörmann
Email: send email
Telefono: 498929000000
Fax: 498929000000

DE (MUENCHEN) participant 657˙547.00
5    FREIE UNIVERSITAET BERLIN

 Organization address address: Kaiserswertherstrasse 16-18
city: BERLIN
postcode: 14195

contact info
Titolo: Ms.
Nome: Tanja
Cognome: Binder
Email: send email
Telefono: +49 3083856751
Fax: +49 3083853448

DE (BERLIN) participant 523˙735.00
6    TOXI-COOP TOXIKOLOGIAI KUTATO KOZPONT ZARTKORUEN MUKODO RT

 Organization address address: DERES UTCA 10 A
city: BUDAPEST
postcode: 1124

contact info
Titolo: Dr.
Nome: Gabor
Cognome: Hirka
Email: send email
Telefono: +36 308462664
Fax: +36 87481681

HU (BUDAPEST) participant 500˙275.00
7    COSMOPHOS LTD

 Organization address address: ADRIANOUPOLEOS 1A
city: THESSALONIKI
postcode: 55133

contact info
Titolo: Dr.
Nome: Panagiotis
Cognome: Trohopoulos
Email: send email
Telefono: +30 2310237222
Fax: +30 2310237222

EL (THESSALONIKI) participant 499˙540.00
8    EURAM LIMITED

 Organization address address: "Tower House, Lucy Tower Street"
city: LINCOLN
postcode: LN1 1XW

contact info
Titolo: Mr.
Nome: Nigel
Cognome: Lambert
Email: send email
Telefono: +44 115 98 11 33 5

UK (LINCOLN) participant 374˙400.00
9    POHJOIS-SAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA

 Organization address address: Puijonlaaksontie 2
city: Kuopio
postcode: FIN-70211

contact info
Titolo: Dr.
Nome: Kirsi
Cognome: Luoto
Email: send email
Telefono: +35 8447172102

FI (Kuopio) participant 346˙895.20
10    STICHTING KATHOLIEKE UNIVERSITEIT

 Organization address address: GEERT GROOTEPLEIN NOORD 9
city: NIJMEGEN
postcode: 6525 EZ

contact info
Titolo: Mr.
Nome: Wim
Cognome: Van Oijen
Email: send email
Telefono: +31 243614314

NL (NIJMEGEN) participant 328˙120.00
11    IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE

 Organization address address: "Via Adamello, 16"
city: MILAN
postcode: 20139

contact info
Titolo: Mr.
Nome: Carlo
Cognome: Raimondi Cominesi
Email: send email
Telefono: +39 02574303256
Fax: +39 02574303231

IT (MILAN) participant 312˙592.40
12    KATHOLIEKE UNIVERSITEIT LEUVEN

 Organization address address: Oude Markt 13
city: LEUVEN
postcode: 3000

contact info
Titolo: Ms.
Nome: Tine
Cognome: Heylen
Email: send email
Telefono: 3216326520
Fax: 3216326515

BE (LEUVEN) participant 310˙088.00
13    BIOCONTRACT SP ZOO

 Organization address address: ULICA ZAMBROWSKA 36
city: POZNAN
postcode: 61051

contact info
Titolo: Prof.
Nome: Andrzej
Cognome: Mackiewicz
Email: send email
Telefono: 48601351342
Fax: +48 618528502

PL (POZNAN) participant 303˙032.00
14    UNIVERSITEIT UTRECHT

 Organization address address: Heidelberglaan 8
city: UTRECHT
postcode: 3584 CS

contact info
Titolo: Mr.
Nome: Martin
Cognome: De Geest
Email: send email
Telefono: +31 302532205

NL (UTRECHT) participant 284˙337.75
15    ETHNIKO IDRYMA EREVNON

 Organization address address: Vassileos Constantinou Avenue 48
city: ATHENS
postcode: 11635

contact info
Titolo: Mrs.
Nome: Ioanna
Cognome: Petrohilou
Email: send email
Telefono: +30 2107273512
Fax: +30 2107246618

EL (ATHENS) participant 223˙194.00
16    SEMMELWEIS EGYETEM

 Organization address address: Ulloi ut 26
city: BUDAPEST
postcode: 1085

contact info
Titolo: Dr.
Nome: Vilmos
Cognome: Ivády
Email: send email
Telefono: +36 13179055

HU (BUDAPEST) participant 210˙652.00
17    Fujikura Europe Ltd

 Organization address address: "C51 Barwell Business Park, Leatherhead Road"
city: Chessington
postcode: KT9 2NY

contact info
Titolo: Mr.
Nome: Paul
Cognome: Rolph
Email: send email
Telefono: +44 2082402015
Fax: +44 2082402010

UK (Chessington) participant 75˙060.00
18    "FIBERTECH CO., LTD"

 Organization address address: "KANDA-NISHIKI-CHO 3-23, CHIYODA-KU, NISHIMOTO KOSAN NISHIKICHO BLDG 10F"
city: TOKYO CHIYODA-KU
postcode: 101-0054

contact info
Titolo: Ms.
Nome: Keiko
Cognome: Nishimura
Email: send email
Telefono: +81 3 5259 7604
Fax: +81 3 5259 1155

JP (TOKYO CHIYODA-KU) participant 0.00
19    LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE

 Organization address address: HIMES HALL 202
city: BATON ROUGE
postcode: 70803

contact info
Titolo: Ms.
Nome: Darya
Cognome: Courville
Email: send email
Telefono: +1 2255782760
Fax: +1 2255782751

US (BATON ROUGE) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

cad    vivo    regulatory    molecular    follow    monitoring    nonclinical    theranostic    coronary    time    endovascular    healthcare    months    nano    imaging    successful    atherosclerotic    near    nanomedicines    global    cosmophos    therapy    medical    approval    real    infrared   

 Obiettivo del progetto (Objective)

'CosmoPHOS-nano is a multidisciplinary, translational and business-oriented project, aiming to accomplish the following objectives: 1) develop the CosmoPHOS system, which is a novel theranostic (diagnostic & therapeutic) nanotechnology-enabled portable combination system enabling endovascular in vivo near-infrared fluorescence molecular imaging, endovascular near-infrared targeted photodynamic therapy, real-time & follow-up therapy monitoring of atherosclerotic coronary artery disease (CAD), 2) nonclinically evaluate this system, 3) clinically validate the system after regulatory approval, & 4) reduce in the long-term CAD deaths and morbidity by up to 40%, resulting in a significant decrease of the European and global healthcare costs for CAD, increasing the income of the European healthcare industry from CAD market which is the global largest. The CosmoPHOS-nano consortium has a five year history of successful collaboration between the industrial and academic partners, and its funding would underpin a team devoted to delivering a novel powerful & affordable healthcare solution against the leading cause of death, without the need for heavy and expensive medical equipment. The CosmoPHOS system consists of two interacting components: a) targeted theranostic near-infrared photoactivatable biocompatible nanomedicines, and b) medical devices. After systemic administration, the nanomedicines targeted accumulate in coronary atherosclerotic plaques, followed by endocoronary photoactivation and detection by the medical devices, enabling molecular imaging, targeted therapy, real-time & follow-up therapy monitoring of CAD. Preliminary in vitro & in vivo successful experimental results, as well as parts of the CosmoPHOS system are already available from the prior five year collaboration. The project plan includes: A) nonclinical R&D (30 months); B) nonclinical validation & regulatory approval (18 months); C) first-in-man phase-I clinical trial in 20 CAD patients (12 months).'

Altri progetti dello stesso programma (FP7-NMP)

CLAFIS (2013)

"CLAFIS - Crop, Livestock and Forests Integrated System for Intelligent Automation, Processing and Control"

Read More  

EEEMBEDDED (2013)

Collaborative Holistic Design Laboratory and Methodology for Energy-Efficient Embedded Buildings

Read More  

MINAM 2.0 (2010)

"Paving the ground for the second generation of a highly effective, application oriented MicroNano Manufacturing community in Europe"

Read More